$4.83 Billion is the total value of RTW INVESTMENTS, LP's 106 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 10.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ILMN | Buy | ILLUMINA INC | $177,976,000 | -4.6% | 509,375 | +3.9% | 3.68% | +35.2% |
| MASI | Buy | MASIMO CORP | $164,110,000 | -34.1% | 1,127,593 | +32.7% | 3.40% | -6.5% |
| PEN | Buy | PENUMBRA INC | $147,910,000 | -17.1% | 665,871 | +7.2% | 3.06% | +17.5% |
| GMED | Buy | GLOBUS MED INCcl a | $124,119,000 | +2.9% | 1,682,291 | +0.7% | 2.57% | +45.9% |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $113,534,000 | +27.7% | 4,794,499 | +84.4% | 2.35% | +81.0% |
| CCCC | Buy | C4 THERAPEUTICS INC | $109,946,000 | +36.9% | 4,531,982 | +81.6% | 2.28% | +94.0% |
| ARGX | Buy | ARGENX SEsponsored adr | $106,253,000 | -4.4% | 336,978 | +6.2% | 2.20% | +35.5% |
| CUTR | Buy | CUTERA INC | $105,312,000 | +82.4% | 1,526,263 | +9.2% | 2.18% | +158.6% |
| PMVP | Buy | PMV PHARMACEUTICALS INC | $80,618,000 | +17.1% | 3,872,154 | +29.9% | 1.67% | +65.9% |
| NTRA | Buy | NATERA INC | $77,995,000 | -55.2% | 1,917,283 | +3.0% | 1.61% | -36.5% |
| RLMD | Buy | RELMADA THERAPEUTICS INC | $68,557,000 | +39.2% | 2,540,074 | +16.2% | 1.42% | +97.4% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $56,003,000 | +5.8% | 1,276,276 | +46.8% | 1.16% | +49.9% |
| IMCR | Buy | IMMUNOCORE HLDGS PLCads | $55,598,000 | +30.4% | 1,859,471 | +49.3% | 1.15% | +84.8% |
| OM | Buy | OUTSET MED INC | $40,844,000 | -0.9% | 899,652 | +0.6% | 0.84% | +40.4% |
| QTRX | Buy | QUANTERIX CORP | $36,444,000 | +25.2% | 1,248,517 | +81.9% | 0.75% | +77.4% |
| JNCE | Buy | JOUNCE THERAPEUTICS INC | $31,780,000 | +32.9% | 4,680,412 | +63.5% | 0.66% | +88.5% |
| IMUX | Buy | IMMUNIC INC | $30,572,000 | +86.2% | 2,705,513 | +57.7% | 0.63% | +163.8% |
| New | CINCOR PHARMA INC | $24,375,000 | – | 1,389,705 | +100.0% | 0.50% | – | |
| Buy | SCIENCE 37 HOLDINGS INC | $21,610,000 | -56.4% | 4,039,341 | +1.6% | 0.45% | -38.3% | |
| New | 2SEVENTY BIO INC | $20,975,000 | – | 1,229,508 | +100.0% | 0.43% | – | |
| Buy | RENOVACOR INC | $12,723,000 | -37.6% | 3,000,803 | +13.3% | 0.26% | -11.7% | |
| XGN | Buy | EXAGEN INC | $7,951,000 | -16.8% | 990,143 | +20.5% | 0.16% | +18.7% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS INC | 36 | Q3 2023 | 19.7% |
| MASIMO CORP | 32 | Q3 2023 | 5.8% |
| LA JOLLA PHARMACEUTICAL CO | 31 | Q2 2022 | 9.7% |
| REGENXBIO INC | 30 | Q4 2022 | 10.8% |
| AGENUS INC | 29 | Q2 2022 | 9.0% |
| PTC THERAPEUTICS INC | 28 | Q3 2023 | 12.8% |
| DICERNA PHARMACEUTICALS INC | 28 | Q3 2021 | 10.8% |
| MIRATI THERAPEUTICS INC | 26 | Q3 2023 | 6.2% |
| ARGENX SE | 26 | Q3 2023 | 5.3% |
| VERICEL CORP | 24 | Q3 2023 | 3.9% |
View RTW INVESTMENTS, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | September 19, 2023 | 18,188,457 | - |
| ALLURION TECHNOLOGIES, INC. | August 11, 2023 | 3,457,707 | 7.4% |
| Orchestra BioMed Holdings, Inc. | May 05, 2023 | 5,620,645 | 15.7% |
| Renovacor, Inc.Sold out | April 05, 2023 | 0 | - |
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Aptevo Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ASLAN Pharmaceuticals LtdSold out | February 14, 2023 | 0 | 0.0% |
| Athira Pharma, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| BELLUS Health Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Clearside Biomedical, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View RTW INVESTMENTS, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-03-01 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View RTW INVESTMENTS, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.